DR LAL PATHLABS
|
DR LAL PATHLABS Last 5 Year Balance Sheet History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
Equity - Authorised | ₹108 Cr | ₹108 Cr | ₹108 Cr | ₹108 Cr | ₹108 Cr |
Equity - Issued | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
Equity Paid Up | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 | ₹10.00 |
Share Warrants & Outstandings | ₹58 Cr | ₹58 Cr | ₹40 Cr | ₹33 Cr | ₹28 Cr |
Total Reserves | ₹1,525 Cr | ₹1,360 Cr | ₹1,122 Cr | ₹917 Cr | ₹834 Cr |
Securities Premium | ₹93 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr | ₹93 Cr |
Capital Reserves | ₹-11 Cr | ₹-11 Cr | ₹-3.30 Cr | ₹-3.30 Cr | ₹-3.30 Cr |
Profit & Loss Account Balance | ₹1,351 Cr | ₹1,210 Cr | ₹981 Cr | ₹789 Cr | ₹719 Cr |
General Reserves | ₹102 Cr | ₹84 Cr | ₹71 Cr | ₹61 Cr | ₹53 Cr |
Other Reserves | ₹-11 Cr | ₹-16 Cr | ₹-20 Cr | ₹-24 Cr | ₹-27 Cr |
Reserve excluding Revaluation Reserve | ₹1,525 Cr | ₹1,360 Cr | ₹1,122 Cr | ₹917 Cr | ₹834 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹1,666 Cr | ₹1,502 Cr | ₹1,245 Cr | ₹1,033 Cr | ₹945 Cr |
Minority Interest | ₹33 Cr | ₹35 Cr | ₹31 Cr | ₹21 Cr | ₹5.48 Cr |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹83 Cr | ₹167 Cr | - | - | - |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | ₹167 Cr | ₹250 Cr | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹-83 Cr | ₹-83 Cr | - | - | - |
Unsecured Loans | - | ₹0.13 Cr | ₹0.12 Cr | - | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | - | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | ₹0.13 Cr | ₹0.12 Cr | - | - |
Deferred Tax Assets / Liabilities | ₹-37 Cr | ₹-33 Cr | ₹-27 Cr | ₹-23 Cr | ₹-21 Cr |
Deferred Tax Assets | ₹40 Cr | ₹38 Cr | ₹31 Cr | ₹27 Cr | ₹25 Cr |
Deferred Tax Liability | ₹2.94 Cr | ₹5.03 Cr | ₹3.52 Cr | ₹3.99 Cr | ₹3.39 Cr |
Other Long Term Liabilities | ₹130 Cr | ₹139 Cr | ₹110 Cr | ₹93 Cr | ₹1.22 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | - | - | - | - | - |
Total Non-Current Liabilities | ₹176 Cr | ₹273 Cr | ₹83 Cr | ₹70 Cr | ₹-20 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹156 Cr | ₹147 Cr | ₹144 Cr | ₹118 Cr | ₹80 Cr |
Sundry Creditors | ₹156 Cr | ₹147 Cr | ₹144 Cr | ₹118 Cr | ₹80 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹214 Cr | ₹227 Cr | ₹108 Cr | ₹94 Cr | ₹41 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹20 Cr | ₹21 Cr | ₹18 Cr | ₹8.58 Cr | ₹6.58 Cr |
Interest Accrued But Not Due | - | - | - | - | - |
Share Application Money | - | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr | ₹0.14 Cr |
Current maturity of Debentures & Bonds | - | - | - | - | - |
Current maturity - Others | - | - | - | - | - |
Other Liabilities | ₹194 Cr | ₹206 Cr | ₹90 Cr | ₹85 Cr | ₹34 Cr |
Short Term Borrowings | ₹70 Cr | ₹95 Cr | - | - | - |
Secured ST Loans repayable on Demands | ₹70 Cr | ₹95 Cr | - | - | - |
Working Capital Loans- Sec | ₹70 Cr | ₹95 Cr | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹-70 Cr | ₹-95 Cr | - | - | - |
Short Term Provisions | ₹30 Cr | ₹30 Cr | ₹22 Cr | ₹16 Cr | ₹18 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹0.50 Cr | ₹3.16 Cr | ₹4.94 Cr | ₹0.19 Cr | ₹4.55 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹29 Cr | ₹27 Cr | ₹17 Cr | ₹15 Cr | ₹13 Cr |
Total Current Liabilities | ₹470 Cr | ₹500 Cr | ₹274 Cr | ₹227 Cr | ₹138 Cr |
Total Liabilities | ₹2,345 Cr | ₹2,310 Cr | ₹1,633 Cr | ₹1,351 Cr | ₹1,069 Cr |
ASSETS | |||||
Gross Block | ₹1,807 Cr | ₹1,726 Cr | ₹684 Cr | ₹574 Cr | ₹302 Cr |
Less: Accumulated Depreciation | ₹502 Cr | ₹357 Cr | ₹236 Cr | ₹161 Cr | ₹93 Cr |
Less: Impairment of Assets | - | - | - | - | - |
Net Block | ₹1,305 Cr | ₹1,369 Cr | ₹447 Cr | ₹413 Cr | ₹209 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹2.97 Cr | ₹14 Cr | ₹6.13 Cr | ₹10 Cr | ₹3.44 Cr |
Non Current Investments | - | - | - | - | - |
Long Term Investment | - | - | - | - | - |
Quoted | - | - | - | - | - |
Unquoted | - | - | - | - | - |
Long Term Loans & Advances | ₹35 Cr | ₹40 Cr | ₹27 Cr | ₹20 Cr | ₹17 Cr |
Other Non Current Assets | ₹27 Cr | ₹11 Cr | ₹4.13 Cr | ₹14 Cr | ₹26 Cr |
Total Non-Current Assets | ₹1,372 Cr | ₹1,435 Cr | ₹488 Cr | ₹459 Cr | ₹255 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹150 Cr | ₹65 Cr | ₹59 Cr | ₹164 Cr | ₹185 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹150 Cr | ₹65 Cr | ₹59 Cr | ₹164 Cr | ₹185 Cr |
Inventories | ₹34 Cr | ₹53 Cr | ₹43 Cr | ₹57 Cr | ₹29 Cr |
Raw Materials | - | - | - | - | - |
Work-in Progress | - | - | - | - | - |
Finished Goods | - | - | - | - | - |
Packing Materials | - | - | - | - | - |
Stores Ā and Spare | ₹34 Cr | ₹52 Cr | ₹42 Cr | ₹57 Cr | ₹27 Cr |
Other Inventory | ₹0.22 Cr | ₹0.82 Cr | ₹0.85 Cr | ₹0.43 Cr | ₹1.04 Cr |
Sundry Debtors | ₹71 Cr | ₹85 Cr | ₹67 Cr | ₹51 Cr | ₹53 Cr |
Debtors more than Six months | ₹32 Cr | ₹31 Cr | ₹11 Cr | ₹15 Cr | ₹10 Cr |
Debtors Others | ₹73 Cr | ₹83 Cr | ₹77 Cr | ₹53 Cr | ₹56 Cr |
Cash and Bank | ₹665 Cr | ₹618 Cr | ₹926 Cr | ₹569 Cr | ₹490 Cr |
Cash in hand | ₹1.18 Cr | ₹1.42 Cr | ₹1.49 Cr | ₹0.83 Cr | ₹1.82 Cr |
Balances at Bank | ₹664 Cr | ₹616 Cr | ₹925 Cr | ₹568 Cr | ₹488 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹34 Cr | ₹34 Cr | ₹32 Cr | ₹30 Cr | ₹24 Cr |
Interest accrued on Investments | ₹22 Cr | ₹20 Cr | ₹24 Cr | ₹20 Cr | ₹17 Cr |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹13 Cr | ₹14 Cr | ₹8.17 Cr | ₹9.27 Cr | ₹7.39 Cr |
Other current_assets | - | - | - | - | - |
Short Term Loans and Advances | ₹19 Cr | ₹20 Cr | ₹19 Cr | ₹21 Cr | ₹32 Cr |
Advances recoverable in cash or in kind | ₹2.85 Cr | ₹4.19 Cr | ₹3.14 Cr | ₹6.71 Cr | ₹1.90 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | ₹20 Cr |
Other Loans & Advances | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹10 Cr |
Total Current Assets | ₹973 Cr | ₹875 Cr | ₹1,145 Cr | ₹893 Cr | ₹814 Cr |
Net Current Assets (Including Current Investments) | ₹503 Cr | ₹375 Cr | ₹871 Cr | ₹665 Cr | ₹675 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹2,345 Cr | ₹2,310 Cr | ₹1,633 Cr | ₹1,351 Cr | ₹1,069 Cr |
Contingent Liabilities | ₹14 Cr | ₹13 Cr | ₹10 Cr | ₹10 Cr | ₹8.38 Cr |
Total Debt | ₹237 Cr | ₹346 Cr | ₹0.12 Cr | - | - |
Book Value | - | 173.17 | 144.61 | 119.97 | 110.08 |
Adjusted Book Value | 192.88 | 173.17 | 144.61 | 119.97 | 110.08 |
Compare Balance Sheet of peers of DR LAL PATHLABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR LAL PATHLABS | ₹18,422.6 Cr | 12.9% | -7.3% | 19.6% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹88,715.9 Cr | 3.4% | -6.6% | 49% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹75,026.8 Cr | 5.7% | -8.7% | 59.1% | Stock Analytics | |
GLOBAL HEALTH | ₹37,656.8 Cr | 6.7% | -13.1% | 164.4% | Stock Analytics | |
FORTIS HEALTHCARE | ₹32,512.3 Cr | 2.6% | -6.4% | 59.4% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹25,374.5 Cr | 2% | -9.6% | 59.5% | Stock Analytics |
DR LAL PATHLABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR LAL PATHLABS | 12.9% |
-7.3% |
19.6% |
SENSEX | -2.6% |
-0% |
21% |
You may also like the below Video Courses